The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Common Severe Infections in Chronic Granulomatous Disease
Open accessAbstract
BACKGROUND: Chronic granulomatous disease (CGD) is due to defective nicotinamide adenine dinucleotide phosphate oxidase activity and characterized by recurrent infections with a limited spectrum of bacteria and fungi as well as inflammatory complications. To understand the impact of common severe infections in CGD, we examined the records of 268 patients followed at a single center over 4 decades. METHODS: All patients had confirmed diagnoses of CGD, and genotype was determined where possible. Medical records were excerpted into a standard format. Microbiologic analyses were restricted to Staphylococcus, Burkholderia, Serratia, Nocardia, and Aspergillus. RESULTS: Aspergillus incidence was estimated at 2.6 cases per 100 patient-years; Burkholderia, 1.06 per 100 patient-years; Nocardia, 0.81 per 100 patient-years; Serratia, 0.98 per 100 patient-years, and severe Staphylococcus infection, 1.44 per 100 patient-years. Lung infection occurred in 87% of patients, whereas liver abscess occurred in 32%. Aspergillus incidence was 55% in the lower superoxide-producing quartiles (quartiles 1 and 2) but only 41% in the higher quartiles (rate ratio, <0.0001). Aspergillus and Serratia were somewhat more common in lower superoxide producing gp91phox deficiency. The median age at death has increased from 15.53 years before 1990 to 28.12 years in the last decade. Fungal infection carried a higher risk of mortality than bacterial infection and was the most common cause of death (55%). Gastrointestinal complications were not associated with either infection or mortality. CONCLUSIONS: Fungal infections remain a major determinant of survival in CGD. X-linked patients generally had more severe disease, and this was generally in those with lower residual superoxide production. Survival in CGD has increased over the years, but infections are still major causes of morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728
Self-citationA Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
The International Chronic Granulomatous Disease Cooperative Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240801 · Cited by 830
Chronic Granulomatous Disease: The European Experience
van den Berg, J. M., van Koppen, E., Åhlin, A., Belohradsky, B. H., Bernatowska, E., Corbeel, L., Español, T., Fischer, A., Kurenko-Deptuch, M., Mouy, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005234 · Cited by 687
Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
Kuhns, D. B., Alvord, W. G., Heller, T., Feld, J. J., Pike, K. M., Marciano, B. E., Uzel, G., DeRavin, S. S., Priel, D. A. L., Soule, B. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007097 · Cited by 568
Self-citationMatute, J. D., Arias, A. A., Wright, N. A. M., Wrobel, I., Waterhouse, C. C. M., Li, X. J., Marchal, C. C., Stull, N. D., Lewis, D. B., Steele, M., et al. (2009) · Blood · doi:10.1182/blood-2009-07-231498 · Cited by 419
Itraconazole to Prevent Fungal Infections in Chronic Granulomatous Disease
Gallin, J. I., Alling, D. W., Malech, H. L., Wesley, R., Koziol, D., Marciano, B., Eisenstein, E. M., Turner, M. L., DeCarlo, E. S., Starling, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021931 · Cited by 400
Self-citationHolland, S. M. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.11.002 · Cited by 348
Self-citationHematologically Important Mutations: X-Linked Chronic Granulomatous Disease—An Update
Heyworth, P. G., Curnutte, J. T., Rae, J., Noack, D., & Cross, A. R. (1997) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.1997.0163 · Cited by 267
Trimethoprim-Sulfamethoxazole Prophylaxis in the Management of Chronic Granulomatous Disease
Margolis, D. M., Melnick, D. A., Ailing, D. W., & Gallin, J. I. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.3.723 · Cited by 261
Self-citationIncidence, severity, and prevention of infections in chronic granulomatous disease
Mouy, R., Fischer, A., Vilmer, E., Seger, R., & Griscelli, C. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80693-6 · Cited by 258
Long-Term Interferon- Therapy for Patients with Chronic Granulomatous Disease
Marciano, B. E., Wesley, R., De Carlo, E. S., Anderson, V. L., Barnhart, L. A., Darnell, D., Malech, H. L., Gallin, J. I., & Holland, S. M. (2004) · Clinical Infectious Diseases · doi:10.1086/422993 · Cited by 251
Self-citationJones, L. B. K. R., McGrogan, P., Flood, T. J., Gennery, A. R., Morton, L., Thrasher, A., Goldblatt, D., Parker, L., & Cant, A. J. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03644.x · Cited by 242
Hematologically important mutations: X-linked chronic granulomatous disease (third update)
Roos, D., Kuhns, D. B., Maddalena, A., Roesler, J., Lopez, J. A., Ariga, T., Avcin, T., de Boer, M., Bustamante, J., Condino-Neto, A., et al. (2010) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2010.07.012 · Cited by 202
Self-citationChronic granulomatous disease: Overview and hematopoietic stem cell transplantation
Kang, E. M., Marciano, B. E., DeRavin, S., Zarember, K. A., Holland, S. M., & Malech, H. L. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.028 · Cited by 185
Self-citationRoos, D., Kuhns, D. B., Maddalena, A., Bustamante, J., Kannengiesser, C., de Boer, M., van Leeuwen, K., Köker, M. Y., Wolach, B., Roesler, J., et al. (2010) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2010.01.009 · Cited by 164
Self-citationSegal, B. H., Barnhart, L. A., Anderson, V. L., Walsh, T. J., Malech, H. L., & Holland, S. M. (2005) · Clinical Infectious Diseases · doi:10.1086/430068 · Cited by 163
Self-citationInvasive Mold Infections in Chronic Granulomatous Disease: A 25-Year Retrospective Survey
Blumental, S., Mouy, R., Mahlaoui, N., Bougnoux, M., Debré, M., Beauté, J., Lortholary, O., Blanche, S., & Fischer, A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir731 · Cited by 138
Invasive aspergillosis in chronic granulomatous disease
Segal, B. H., & Romani, L. R. (2009) · Medical Mycology · doi:10.1080/13693780902736620 · Cited by 122
Inheritance Pattern and Clinical Aspects of 93 Iranian Patients with Chronic Granulomatous Disease
Fattahi, F., Badalzadeh, M., Sedighipour, L., Movahedi, M., Fazlollahi, M. R., Mansouri, S. D., Khotaei, G. T., Bemanian, M. H., Behmanesh, F., Hamidieh, A. A., et al. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9567-x · Cited by 122
Beauté, J., Obenga, G., Mignot, L. L., Mahlaoui, N., Bougnoux, M., Mouy, R., Gougerot‐Pocidalo, M., Barlogis, V., Suárez, F., Lanternier, F., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181f13b23 · Cited by 114
Hepatic Involvement and Portal Hypertension Predict Mortality in Chronic Granulomatous Disease
Feld, J. J., Hussain, N., Wright, E. C., Kleiner, D. E., Hoofnagle, J. H., Ahlawat, S., Anderson, V., Hilligoss, D. M., Gallin, J. I., Liang, T. J., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.081 · Cited by 110
Self-citationChronic granulomatous disease in Israel: Clinical, functional and molecular studies of 38 patients
Wolach, B., Gavrieli, R., de Boer, M., Gottesman, G., Ben‐Ari, J., Rottem, M., Schlesinger, Y., Grisaru‐Soen, G., Etzioni, A., & Roos, D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.06.012 · Cited by 99
Falcone, E. L., & Holland, S. M. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328358b0a4 · Cited by 94
Self-citationInvasive fungal infections in congenital immunodeficiencies
Antachopoulos, C. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03289.x · Cited by 80
Greenberg, D. E., Goldberg, J. B., Stock, F., Murray, P. R., Holland, S. M., & LiPuma, J. J. (2009) · Clinical Infectious Diseases · doi:10.1086/598937 · Cited by 76
Self-citationChronic granulomatous disease of childhood
Dr., N. L. P., & Levine, C. C. (2004) · Springer eBooks · doi:10.1007/3-540-29668-9_581 · Cited by 53
Reinfection, Rather than Persistent Infection, in Patients with Chronic Granulomatous Disease
Guide, S. V., Stock, F., Gill, V. J., Anderson, V., Malech, H. L., Gallin, J. I., & Holland, S. M. (2003) · The Journal of Infectious Diseases · doi:10.1086/368388 · Cited by 52
Self-citationA Twice Daily Posaconazole Dosing Algorithm for Children With Chronic Granulomatous Disease
Welzen, M. E. B., Brüggemann, R. J. M., van den Berg, J. M., et al. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182195808 · Cited by 50
Diabetes, Renal and Cardiovascular Disease in p47 phox−/− Chronic Granulomatous Disease
Leiding, J. W., Marciano, B. E., Zerbe, C. S., Ravin, S. S. D., Malech, H. L., & Holland, S. M. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9871-8 · Cited by 23
Self-citationKepenekli, E., Soysal, A., Kuzdan, C., Ermerak, N. O., Yüksel, M., & Bakır, M. (2014) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-40-2 · Cited by 6
Cited by
Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases
Kak, G., Raza, M., & Tiwari, B. K. (2018) · Biomolecular Concepts · doi:10.1515/bmc-2018-0007 · Cited by 617
Holland, S. M. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.11.002 · Cited by 348
Self-citationSuperoxide Anion Chemistry—Its Role at the Core of the Innate Immunity
Andrés, C. M. C., Pérez de la Lastra, J. M., Andrés Juan, C., Plou, F. J., & Pérez-Lebeña, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031841 · Cited by 342
Microbial antioxidant defense enzymes
Staerck, C., Gastebois, A., Vandeputte, P., Calenda, A., Larcher, G., Gillmann, L., Papon, N., Bouchara, J.-P., & Fleury, M. J. J. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.06.015 · Cited by 288
NADPH oxidase activation in neutrophils: Role of the phosphorylation of its subunits
Belambri, S. A., Rolas, L., Raad, H., Hurtado‐Nedelec, M., Dang, P. M., & El‐Benna, J. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12951 · Cited by 265
Metadata
- Authors
- Marciano, B. E., Spalding, C., Fitzgerald, A., Mann, D., Brown, T., Osgood, S., Yockey, L., Darnell, D. N., Barnhart, L., Daub, J., Boris, L., Rump, A. P., Anderson, V. L., Haney, C., Kuhns, D. B., Rosenzweig, S. D., Kelly, C., Zelazny, A., Mason, T., DeRavin, S. S., Kang, E., Gallin, J. I., Malech, H. L., Olivier, K. N., Uzel, G., Freeman, A. F., Heller, T., Zerbe, C. S., & Holland, S. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-12-23
- Volume
- 60
- Issue
- 8
- Pages
- 1176-1183
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2061652403
- Cited by
- 423
- References
- 31
- FWCI
- 9.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.